NEW MJ NEWS

High Tide to Announce Fourth Quarter and Full Fiscal Year 2023 Financial Results

High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it will release its financial and operational results for the quarter and year ended October 31, 2023, after financial markets close on Monday, January 29, 2024. High Tide’s fourth quarter and year-end 2023 financial and operational results will be available on SEDAR+, EDGAR, and on the Company’s website at https://hightideinc.com/invest.

Following the release of its fourth quarter and year-end financial and operational results, High Tide will host a webcast with Raj Grover, Founder and Chief Executive Officer, and Sergio Patino, Chief Financial Officer, to discuss the Company’s financial results and its plans for 2024, at 11:30 AM Eastern Time on Tuesday, January 30.

Webcast Link for High Tide Earnings Event:

https://events.q4inc.com/attendee/307349204

Participants are encouraged to pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above.

Participants who wish to ask questions during the event may do so through the call-in line, the access information for which is as follows:

Canada (Local): 1 226 828 7575
Canada (Toll-Free): 1 833 950 0062
United States (Local): 1 404 975 4839
United States (Toll-Free): 1 833 470 1428
Global Dial-In Numbers: https://www.netroadshow.com/events/global-numbers?confId=59676
Participant Access Code: 499316

*Participants will need to enter the participant access code before being met by a live operator*

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world’s most powerful plant. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Bricks & Mortar Retail: Canna Cabana™ is the largest non-franchised cannabis retail chain in Canada, with 162 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba and Ontario and growing. In 2021, Canna Cabana became the first cannabis discount club retailer in North America.

Story Continues

View Comments
Terms/Privacy PolicyPrivacy DashboardAbout Our Ads

Bloomberg
Grifols Set for Biggest Weekly Drop Ever on Short Seller Tumult

1 / 2
Grifols Set for Biggest Weekly Drop Ever on Short Seller Tumult
Macarena Muñoz
Fri, Jan 12, 2024, 5:22 AM EST2 min read

In This Article:
GRF.MC
-9.98%
GRFS
-13.95%
(Bloomberg) — Grifols SA shares slumped anew, putting the stock on a pace for its biggest weekly drop ever after a short seller criticized the Spanish blood-plasma company’s accounting and corporate governance.

Most Read from Bloomberg

Google Lays Off Hundreds in Hardware, Assistant, Engineering

US and UK Strike Yemen’s Houthis After Red Sea Ship Attacks

Hertz to Sell 20,000 EVs in Shift Back to Gas-Powered Cars

UK’s Sunak Authorizes Joint Military Strikes With US Against Houthis

BlackRock Buys Infrastructure Firm GIP for $12.5 Billion in Major Alternatives Push

Shares of the Barcelona-based company sank 12% Friday to €8.72 at 11:22 a.m. They’re now down almost 40% since Gotham City Research LLC’s report Tuesday. Management efforts to reassure investors have done little to sustain the stock, with the company’s market value shrinking by €3.3 billion ($3.6 billion).

Gotham City said Grifols’s financial statements included earnings from BPC Plasma and Haema, two companies for which Grifols has a call option and that are owned by Scranton Enterprises NV, an investment vehicle for some members of the Grifols founding family and a group of former executives.

Following two regulatory filings rebutting Gotham’s accusations, company management held a call Thursday in which Chief Executive Officer Thomas Glanzmann accused Gotham City of “re-purposing financial information” and acting out of “pure self-interest and financial gain” and reiterated that the board will take legal action against the firm.

He said Spanish securities regulator CNMV has asked the company to provide more information following the short seller report.

The call failed to reassure investors, with the stock slumping 16% Thursday. It’s now set for the biggest weekly drop ever in the company’s 18 years on the stock market.

Grifols “fell short of appeasing investor concerns given the steep market reaction,” JB Capital analyst Joaquin Garcia-Quiros said in a note Friday. “More information on the Scranton balance sheet situation, as well as providing a reassurance that such third-party transactions would never happen again, would have helped.”

Investors would have welcomed cash flow figures for 2024, he said, and “the absence of a material reassurance led to the negative reaction, even though we are surprised by the magnitude of that reaction.”

Investors also have been focused on Grifols’ debt pile, which totaled €9.5 billion as of September, with maturities of almost €2 billion due in 2025.

Analysts overall are still backing the company: Grifols stock has 19 buy recommendations, five holds and one sell, according to data compiled by Bloomberg, little changed from before the Gotham City report.

The slide in Grifols stock is a buying opportunity, Banco Santander SA said in a note Friday.

The shares may have dropped Thursday because the company said its agreement to sell an investment — a key for the company to reduce its indebtedness — doesn’t contain any penalties if either side pulls out, analyst Jaime Escribano wrote. In a followup conversation with Grifols, the company said the process to sell most of its stake in Shanghai RAAS Blood Products Co. to Haier Group for about $1.8 billion was well on track, he said.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

InMed Pharmaceuticals Inc. (IMLFF) Announces NSERC Grant to The University of British Columbia

InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in…

Emerald Health Therapeutics, Inc. (ATTBF) Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation

Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to…

Tetra Bio-Pharma Inc. (TBPMF) names Aphria CFO as Chairman of Audit Committee

Tetra Bio-Pharma names Aphria CFO as Chairman of Audit Committee Tetra Bio-Pharma…